Company Filing History:
Years Active: 2012
Title: The Innovations of Peter Amon
Introduction
Peter Amon is a notable inventor based in Gilching, Germany. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that target cancer treatment. His work focuses on creating innovative solutions that can potentially improve patient outcomes.
Latest Patents
Peter Amon holds a patent for Raf inhibitors, specifically derivatives of pyrido[2,3-d]pyrimidin-7-one. This invention provides compounds that act as inhibitors of kinases such as Raf. These compounds demonstrate anti-proliferative activity against tumor cells and are useful in treating diseases, including cancer. He has 1 patent to his name.
Career Highlights
Amon is currently employed at Forma Therapeutics, Inc., where he continues to advance his research and development efforts. His work at the company emphasizes the importance of innovative therapies in the fight against cancer.
Collaborations
Throughout his career, Peter Amon has collaborated with talented individuals such as Andreas Schoop and Alexander Backes. These partnerships have contributed to the success of his projects and the advancement of cancer treatment research.
Conclusion
Peter Amon is a dedicated inventor whose work in developing Raf inhibitors showcases his commitment to improving cancer therapies. His contributions to the field are invaluable and highlight the importance of innovation in medicine.